On Demand | 4th Meeting on Oncology of Diaspora

Moderators: A. Nikolaidi (GR), F.I. Dimitrakopoulos (GR)

12.00-12.20 Precision and Personalized Medicine in Gynecological Cancers M. Liontos (GR)

12.20-12.40 Molecular classification of endometrial cancer E. Kavoura (GR)

12.40-13.00 Therapeutic Strategies for Cervical Malignancies G. Tsironis (CY)

13.00-13.20 First- and Second-Line Therapies in Endometrial Cancer A. Koliadou (SE)

13.20-13.40 Clinical Implications of PARP Inhibitor in Ovarian Cancer Treatment: State of the Art and Future Perspectives S. Linardopoulos (UK)

13.40-14.00 Discussion

Moderators: T. Mamounas (US), G. Fotopoulos (CY)

16.30-16.50 Personalized or massive screening S. Douvetzemis (GR)

16.50-17.10 HR-Positive Breast Cancer adjuvant: Selecting Therapy after adjuvant chemotherapy A. Matikas (SE)

17.10-17.30 Gene signatures in decision making A. Valachis (SE)

17.30-17.40 Discussion

Hall I: Oncology pipeline: GI vision E. Anastasopoulou (GR)

Moderators: I. Athanasiadis (GR), V. Karantza (US)

18.00-18.20 ER, HER2-Positive Metastatic Breast Cancer: Where are We Headed? V. Kaklamanis (US)

18.20-18.40 The future prospective: Immunotherapy V. Karantza (US)

18.40-19.00 Systemic therapy beyond immunotherapy E. Andreopoulou (US)

19.00-19.15 Discussion

Moderators: Ν. Κarachaliou (DE), A. Kotsakis (GR)

Detecting Cancer with Liquid Biopsy. Current state and future hope N. Papadopoulos (US)

Moderators: A. Bamias (GR), Ch. Charalambous (CY)

08.30-08.50 Managing RCC in 2023-Overview of current evidence P. Tsantoulis (CH)

08.50-09.10 Case 1 Patient with newly diagnosed stage III ccRCC following nephrectomy K. Koutsoukos (GR)

09.10-09.30 Case 2 Patient with newly diagnosed mccRCC (Poor/intermediate risk) Ν. Androulakis (GR)

09.30-09.50 Case 3 Patient with mccRCC following progression on first-line Therapy V. Bozionelou (GR)

09.50-10.10 Case 4 Patient with papillary mRCC N. Pistalmatzian (GR)

10.10-10.30 Discussion

Moderators: S. Baritaki (GR), A. Kyriazoglou (GR)

11.00-11.20 Immune Responses Triggered by Abrogation of BRCA1/2 Tumour Suppressors Y. Markou (CY)

11.20-11.40 Next frontiers in immunotherapy in solid tumors D. Papadatos - Pastos (UK)

11.40-12.00 Neoadjuvant vs adjuvant immunotherapy A. Digklia (SUI)

12.00-12.15 Discussion

Moderators: A. Koumarianou (GR), G. Tzimas (GR)

PART 1: DIAGNOSTIC APPROACH

12.15-12.25 Biomarkers and conventional imaging Ch. Toumbanakis (UK)

12.25-12.35 Molecular imaging I. Karfis (BE)

PART 2: THERAPEUTIC STRATEGY

12.35-12.45 Established and emerging options for symptoms’ and tumour growth control Ch. Toumbanakis (UK)

12.45-12.55 The role of Peptide Receptor Radionuclide Therapy I. Karfis (BE)

12.50-13.00 Discussion

Hall 1 Εmerging biomarkers in cancer G. Vasmatzis (US), V. Anagnostou (US)

Hall 2 Artificial Intelligence N. Papanikolaou (PT), K. Marias (GR)

Hall 3 Real World Data/Pragmatic Trials D. Papamichael (CY), Th. Foukakis (SE)

Moderators: I. Souglakos (GR), D. Papamichael (CY)

14.30-14.50 Features and susceptibility to environmentally induced colorectal carcinogenesis/Early Colorectal Cancer M. Giannakis (US)

14.50-15.10 Neoadjuvant Treatment Approaches for Stage II-III Rectal Cancer N. Gouvas (GR)

15.10-15.30 Personalised tt in mCRC D. Papamichael (CY)

15.30-15.50 Native immunity & dysbiosis in Colorectal Cancer I. Messaritakis (CY)

15.50-16.00 Discussion

Moderators: M. Nikolaou (GR), N. Tsoukalas (GR), Th. Tegos (GR)

16.00-16.20 Challenging clinical cases across the prostate cancer disease spectrum A. Patrikidou (FR)

16.20-16.40 Challenging Cases in Breast Cancer A. Constantinidou (CY)

16.40-17.00 A case of Myxoïd Liposarcoma D. Tzanis (FR)

Medical Education opportunities in United States P. Savvides (US)

Moderators: V. Georgoulias (GR), I. Boukovinas (GR)

18.30-19.00 TBD A. Tsimberidou (US)

19.00-19.30 T cell therapy and tumor vasculature - reciprocal modulation G. Coukos (SUI)

19.30-20.00 Critical appraisal of WCLC 2023 K. Leventakos (US)

Moderators: S. Karagiannis (UK), A. Dimou (US)

20.00-20.20 IgE class antibody immunotherapy for solid tumours S. Karagiannis (UK)

20.20 -20.40 Biomarkers on immunotherapy response in urothelial carcinoma P. Grivas (US)

20.40- 21.00 Invariant NKT cell platform for treatment of blood cancers A. Karadimitris (UK)

Moderators: G. Nasioulas (GR), F.I. Dimitrakopoulos (GR)

Tumor Board: P. Christopoulos (DE), G. Vasmatzis (US), V. Anagnostou (US),

K. Linos (US), P. Savvides (US), A. Saetta (GR), Ch. Christopoulos (FR)

Moderators: A. Christopoulou (GR), M. Rovithi (GR)

10.00-10.20 The surgical approach of hepatobiliary Tumors A. Prahalias (UK)

10.20-10.40 Local treatments K. Katsanos (GR)

10.40-11.00 Systemic treatments I. Boukovinas (GR)

Moderators: A. Zygogianni (GR), I. Georgakopoulos (GR)

Radiation Therapy, DNA Damage, and Immune Response H. Gkika (DE)

Anagnostou V.
MD, PhD, Associate Professor, Medical Oncology, Director, Thoracic Oncology Biorepository, Upper Aerodigestive Oncology Program, Co-leader, Molecular Tumor Board, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, USA
Anastasopoulou E.
MSc PhD, Medical Lead Oncology Lung/GU/GI, AstraZeneca, Europe, Western & Southern Europe, Greece
Andreopoulou E.
MD, Professor of Clinical Medicine, Director of the Breast Canc er Center Clinical Research Program, Weill Cornell Medicine Breast Center , New York, USA
Androulakis N.
Head of the Medical Oncology Department, Venizeleio General Hospital of Heraklion, Heraklion, Crete
Athanasiadis I.
Medical Oncologist, Director of Oncology Clinic Mitera Hospital (Hygeia Group), Athens, Greece / Ass. Professor of Oncology, Northwestern University, Chicago, USA
Bamias A.
MD, PhD, MRCP, Professor of Therapeutics-Internal Medicine-Oncology, National & Kapodistrian University of Athens, 2nd Propaedeutic Dept of Internal Medicine, ATTIKON University Hospital, Athens, Greece
Baritaki S.
Αssociate Professor, Experimental Oncology, School of Medicine, University of Crete, Greece
Boukovinas I.
MD, PhD, PharmaD, Medical Oncologist, Head of Oncology Unit, Bioclinic Thessaloniki, Greece
Bozionelou V.
Consultant, Medical Oncologist, University Hospital of Heraklion, Crete
Charalambous C.
BM (Soton) MRCP(UK) FRCR (UK), Consultant Clinical Oncologist, Bank of Cyprus Oncology Centre, Nicosia, Cyprus
Christopoulos C.
Radiation Oncologist, Head of R adiation Oncology Department, Groupe Hospitalier de Territoire Grand Paris Nord-Est, Paris, France
Christopoulos P.
Hematologist / Medical Oncologist, Thoraxklinik and National Center for Tumor Diseases (NCT) at Heidelberg University Hospital, Heidelberg, Germany
Christopoulou A.
MD, PhD, Medical Oncologist, Director in the Oncology Unit, Saint Andrews General Hospital of Patras, Greece
Constantinidou A.
MD, MRCP, MSc, PhD, Medical Oncologist, Medical School University of Cyprus & BoC Oncology Centre, Nicosia, Cyprus
Coukos G.
Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Switzerland
Digklia A.
MD, MSc, Consultant Oncologist, Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland
Dimitrakopoulos F. I.
MD, PhD, Medical Oncologist, Division of Oncology & Molecul ar Oncology Laboratory, Department of Medicine, Univ ersity of Patras, Greece
Dimou A.
MD, Senior Associate Consultant, Division of Medical Oncology, Assistant Professor of Medicine, Mayo Clinic College of Medicine, Rochester, MN, USA
Douvetzemis Stergios
MD, PhD, FRCS, FEBS, Director Breast Surgeon, Metropolitan General Hospital Athens, Honorary Senior Lecturer, King’s College London, Honorary Consultant Oncoplastic Breast Surgeon, Guy’s and St Thomas’ NHS Foundation Trust London, UK
Fotοpoulos G.
MD, PhD, FSMB (USA), Medical Oncology Consultant, UT Health San Antonio MD Anderson Alumni, Bank of Cyprus Oncology Center, Cyprus
Foukakis T.
Associate Professor, Senior Consultant, Department of Oncology-Pathology, Karolinska Institutet, Breast Center, Karolinska University Hospital, Sweden
Georgakopoulos I. I.
Assistant Professor of Radiation Oncology, National and Kapodistrian University of Athens, Aretaieion University Hospital, Athens, Greece
Georgoulias V.
Emeritus Professor of Medical Oncology, School of Medicine, University of Crete, Heraklion, Crete, Greece
Giannakis M.
MD, PhD, Gastrointestinal Cancer Center, Dana-Farber Cancer Institute. Assistant Professor of Medicine, Harvar d Medical School, Boston, USA
Gkika E.
Assoc. Professor, Vice Chair of the department of Radiation Oncology, Universitätsklinikum Freiburg, Freiburg, Germany
Gouvas N.
Assistant Professor of Surgery, University of Cyprus, Medical School Nicosia, Cyprus
Grivas P.
MD, PhD, Associate Professor, Department of Medicine, Division of Medical Oncology, Clinical Director, Genitourinary Cancers Program, University of Washington, Associate Professor, Clinical Research Division, Fred Hutchinson Cancer Research Center, USA
Kaklamanis V.
MD, DSc, Professor of Medicine, Ruth McLean Bowman Bowers, Chair in Breast Cancer Research and Treatment, A.B. Alexander Distinguished Chair in Oncology, Leader, Breast Oncology Program, UT Health San Antonio, MD Anderson Cancer Center, USA
Karachaliou N.
MD, PhD, Medical Director, Global Clinical Development, Merck KGaA, Darmstadt, German
Karadimitris A.
Professor of Haematology, Centre for Haematology, Department of Medicine, Imperial College, London, Honorary Consultant Haematologist, Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, UK
Karagiannis S.
Professor of Translational Cancer Immunology and Immunotherapy, St. John’s Institute of Dermatology, School of Basic & Medical Biosciences , King’s College London, Guy’s Hospital, London, UK
Karatza V.
MD, PhD, AVP, Global Clinical Dev elopment, Women’s Cancers, Sub-Section Head for Breast Cancer, Merck, Sharp & Dohme, USA
Karfis I.
MD, PhD, Nuclear Medicine Department, Institut Jules Bordet/ Hôpital Universitaire de Bruxelles, Belgium
Katsanos K.
MSc, MD, PhD, EBIR, Asst Professor in Interventional Radiology, Patras, University Hospital, School of Medicine, Rion, Patras, Greece
Kavoura E.
MD, PhD Pathologist, IASO General and Gynecologic Clinic, Athens, Greece
Koliadou A.
Kotsakis A.
MD, PhD, Associate Professor of Medical Oncology, Director of Department of Medical Oncology, University Hospital of Larisa, Thessaly, Greece
Koumarianou A.
MD, PhD, Consultant in Medical Oncology, Hematology Oncology Unit, 4th Department of Internal Medicine, Attikon Univ ersity Hospital, Athens
Koutsoukos K.
MD, MCs, Medical Oncologist, Alexandra Hospital, National Kapodistrian University of Athens, Eugenideio Hospital, Athens
Kyriazoglou A
MD, PhD, Medical Oncologist, National & Kapodistrian University of Athens, 2nd Propaedeutic Department of Medicine, Attikon University Hospital, Athens, Greece
Leventakos K.
MD, PhD, Assistant Professor, Chest oncology and clinical studies phase 1, Mayo Clinic, Rochester, USA
Linardopoulos S.
Associate Director, Translational Science, Oncology AstraZeneca - Professor of Cancer Therapeutics, The Insitute of Cancer Research, London, UK
Linos K.
MD, FCAP, FASDP, Associate Professor of Pathology, Geisel School of Medicine at Dartmouth, USA, Bone & Soft Tissue pathology and Dermatopathology Division, Director of Bone & Soft Tissue Pathology Division, Dartmouth Hitchcock Medical Center , USA
Liontos M.
PhD, Medical Oncologist, Consultant, Department of Clinical Therapeutics, Alexandra Hospital, Athens, Greece
Mamounas T.
Professor of Surgery, University of Central Florida College of Medicine, Medical Director of Comprehensive Breast Program, Orlando Heath Cancer Institute, Orlando, FL/ Clinical Professor of Clinical Sciences, Florida State University College of Medicine, USA
Marias K.
Head, Computational Biomedicine Laboratory, Institute of Computer Science (ICS), Foundation for Research and Technology - Hellas (FORTH), Professor in Medical Image Processing at the Electrical and Computer Eng. Department of the Hellenic Mediterranean University, Greece
Markou Y.
Consultant Medical Oncologist, MRCP, FRCR, Cyprus
Matikas A.
MD, MSc, PhD, Associate Professor of Oncology | Karolinska Institutet, Senior Consultant in Breast Oncology | Karolinska University Hospital, Stockholm, Sweden
Messaritakis I.
MSc, PhD, Medical Microbiologist, Director of Microbiology Department, Yannoukas Medical Labs, Bioiatriki Group, German Oncology Center, Limassol, Cyprus
Nasioulas G.
PhD, Chief Scientific Officer, Genekor Medical S.A., Athens, Greece
Nikolaidi A.
Medical Oncologist, Mitera Hospital (Hygeia Group), Athens, Greece
Nikolaou Μ.
MD, MSc, PhD, Medical Oncologist, Anti - Cancer Hospital Agios Savvas, Athens, Greece
Papadatos – Pastos D.
MRCP (UK) PhD, Consultant in Medical Oncology, Lung Cancer and Acute Oncology, University College London Hospitals and The Princess Alexandra Hospital, London, UK
Papadopoulos N.
Ph.D., Professor, Oncology and Pathology, Director of Translational Genetics, Ludwig Center for Cancer Genetics & Therapeutics, Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Institutions
Papamichael D.
MB, BS, MD, FRCP, Consultant Medical Oncologist, Director – Department of Medical Oncology, Bank of Cyprus Oncology Centre / Associate Professor, St. George’s Hospital and Medical School, University of London, UK
Papanikolaou Ν.
PhD, Head of Computational Clinical Imaging Group, Centre for the Unknown, Champalimaud Foundation, Lisbon, Portugal, Machine Learning Imaging Lead, Royal Marsden, London, UK, Honorary Reader, The Institute of Cancer Research, London, UK, Affiliated Researcher, Karolinska Institute, Sweden, Senior Affiliated Researcher, Institute of Computer Science, FORTH, Heraklion, Greece
Patrikidou A.
Consultant Medical Oncologist, Genitourinary Oncology Group , Department of Cancer Medicine, Gustave Roussy Institute, University of Paris Saclay, Villejuif, France
Pistamaltzian N.
MD, PhD, Medical Oncologist, Oncology Dpt MITERA Hospital, Athens, Greece
Prahalias A.
MD, PhD, Consultant Surgeon, Hepato-Biliary & Pancreatic Surgery, General Surgery & Liver Transplantation, London Liver Centre, London Bridge Hospital, UK
Rovithi M.
Medical Oncologist, Agios Nikolaos General Hospital, Crete, Greece
Saetta A.
Professor, Unit of Molecular Pathology, 1st Department of Pathology, School of Medicine, National and Kapodistrian University of Athens, Greece
Savvides P.
MD, PhD, MPH, Senior Associate Consultant, Thoracic H&N Medical Oncology, Mayo Clinic Arizona, USA
Souglakos I.
Associate Professor of Medical Oncology, Laboratory of Translational Oncology, Faculty of Medicine, University of Crete, Department of Medical Oncology, University Hospital of Heraklion, Crete, Greece
Tegos Th.
Medical Oncologist, PhD, Evangelismos General Hospital, Athens, Greece
Toumpanakis Ch.
MD, PhD, FRCP, AGAF, FEBGH, Professor of Gastroenterology & Neuroendocrine Tumours, Division of Medicine - Institute of Liver & Digestive Health - University College of London (UCL), Centre for Gastroenterology | Neuroendocrine Tumour Unit - ENETS Centre of Excellence, Royal Free Hospital, London, UK
Tsantoulis P.
MD, PhD, Medical Oncologist, Department of Oncology, Univ ersity Hospital of Geneva, Center for Translational Oncohematology, University of Geneva (HUG), Swiss Cancer Center Leman, Geneva, Switzerland
Tsimperidou A.
MD, PhD, Department of Inv estigational Cancer Therapeutics, Division of Cancer Medicine, MD Anderson Cancer Center, USA
Tsironis G.
MD, PhD, Oncologist, Oncology Unit, Nicosia General Hospital, Cyprus
Tsoukalas N.
MD, MSc, PhD, Medical Oncologist, MSc in Bioinformatics, Deput y Director, Oncology Department, 401 General Military Hospital, Consultant, Henry Dunant Hospital Center, Athens Greece
Tzanis D.
MD, PhD, Department of Surgery, Institut Curie, Paris, France
Tzimas G.
Chief Hepatobiliary Section, Hygeia Hospital, Athens, Greece
Valachis A.
Associate Professor of Oncology, Department of Oncology, Örebro University Hospital, Sweden
Vasmatzis G.
Co-director of the Biomarker Discov ery Laboratory, Mayo Clinic Center for Individualized Medicine, Full Consultant in the Department of M olecular Medicine, Member of the Mayo Clinic Cancer Center, Rochester, USA
Zygogianni A.
Associate Professor of Radiation Oncology, University of Athens, Greece

Technical Support is available:
- everyday 09:00-17:00
- at the day of the event 09:00-21:00
For Technical Support please contact us:
Phone: +30 210 72 40 039
Email: support@livetime.gr

Event Details
Sponsors